Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.
about
MLL5 maintains spindle bipolarity by preventing aberrant cytosolic aggregation of PLK1Characterization of Cep85 - a new antagonist of Nek2A that is involved in the regulation of centrosome disjunctionNek2 activation of Kif24 ensures cilium disassembly during the cell cycleTargeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosisNek2 is a novel regulator of B cell development and immunological response.Role of NEK2A in human cancer and its therapeutic potentials.Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibitionjNMFMA: a joint non-negative matrix factorization meta-analysis of transcriptomics data.Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.Structure-guided design of purine-based probes for selective Nek2 inhibitionNanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference TranscriptomesClinical significance and prognostic value of Nek2 protein expression in colon cancer.Targeting NEK2 as a promising therapeutic approach for cancer treatment.The acetyltransferase Tip60 contributes to mammary tumorigenesis by modulating DNA repair.Cellulase from Trichoderma harzianum interacts with roots and triggers induced systemic resistance to foliar disease in maize.Nek2A/SuFu feedback loop regulates Gli-mediated Hedgehog signaling pathway.Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity.Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance.Identification of potential key genes associated with glioblastoma based on the gene expression profileTargeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity.NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma.Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival.The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2.Protein Kinase Targets in Breast Cancer.Non-mammalian models of multiple endocrine neoplasia type 2.Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis.Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer.NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.Prognostic value of NEK2 overexpression in digestive system cancers: a meta-analysis and systematic reviewGenetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
P2860
Q27310288-517B59CC-7AEE-46B8-860D-3C3EAEBB1B29Q28115684-A0F337DB-7B3F-46E6-B572-A17C52B8D20CQ28118308-0923087B-3D55-4E60-AFE2-C40716726F11Q33591876-8AD0B1D2-AFE4-46A1-B484-96C444C919CFQ33802966-F8B2E3F9-18B4-4BA8-8B08-B526CBA30D59Q34609883-3E98B067-C502-4E2B-94E9-BF1865C2254AQ35090475-804A5292-3E33-47F2-802E-1F1371B7BEEBQ35092019-7A20B0E5-48F6-4483-A301-1DC06308D8D6Q35438574-E6A9A216-AD26-47B1-B8BD-D306763E8493Q35759762-518771FA-08DE-499D-8BC8-8A294B807527Q36189360-C35179C9-5300-41D0-8B3D-EB536C9CBCE7Q36253332-0D252C23-9138-4BAC-BD37-89BBE1ADE181Q36293047-54C91513-A9B0-4938-B461-E0B0A398C4B0Q36465062-4421293B-C6B8-40C7-B3A7-4A3DBF0B7389Q36956969-CBCFC505-8D6A-415D-BB10-18B5D84CC885Q37098823-9E746DF6-69B6-463D-BDDD-F001DBC560D1Q37405641-262BEDC0-1CB7-4397-BD13-12554AD69EBCQ37588070-207D38A8-28FA-40F8-A9A0-69AA8F9C7E02Q37694789-5832418E-6B47-4983-A449-749A0E2ECDA3Q37723758-1AB9A8D3-84E8-4346-BC20-151E21E53818Q38633652-841B564E-6615-485F-82FE-8085FFBD2446Q38665185-4B595675-B538-44DC-863D-B8AB588BCD23Q38721508-F91861B3-5EC5-424A-9537-3A4E6462CA14Q39021563-523CD57E-F19A-4400-AFAC-BA85C669DC13Q41592983-BA0A0C1B-D20B-4A90-9C97-87C85062F7C1Q44052835-AEB26264-C7C3-49BA-8724-107B346BFDA3Q47107372-BB9EBBC7-4450-4FDB-A278-68EA6ABA39F1Q47225930-A4E7BD5E-4B89-4F2A-95FA-32E352967538Q47351355-6CE8301F-3928-414E-9DA2-75C8091FD557Q47724734-44095C49-00B9-4095-9D3A-54123EF129B0Q48008338-34FEBDF1-6318-42DD-8512-529C8D814229Q48250667-13946D65-7D87-4D12-893A-8EDC864EEEF0Q49331594-2A2BE89A-A98A-4080-A547-6617D31A961DQ58694632-D4597562-7E84-4BF1-8C75-D2D6FEB18541Q58766772-8DE85A07-B72F-469F-85F7-175C5B8F1959
P2860
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.
@en
type
label
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.
@en
prefLabel
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.
@en
P2093
P50
P356
P1433
P1476
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells
@en
P2093
N A Miller
P2888
P304
P356
10.1038/ONC.2013.183
P407
P577
2013-05-27T00:00:00Z
P6179
1014388230